BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27277344)

  • 1. Strong preference of BRCA1 protein to topologically constrained non-B DNA structures.
    Brázda V; Hároníková L; Liao JC; Fridrichová H; Jagelská EB
    BMC Mol Biol; 2016 Jun; 17(1):14. PubMed ID: 27277344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The central region of BRCA1 binds preferentially to supercoiled DNA.
    Brázda V; Jagelska EB; Liao JC; Arrowsmith CH
    J Biomol Struct Dyn; 2009 Aug; 27(1):97-104. PubMed ID: 19492866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage.
    Au WW; Henderson BR
    Cell Signal; 2007 Sep; 19(9):1879-92. PubMed ID: 17531442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disintegration of cruciform and G-quadruplex structures during the course of helicase-dependent amplification (HDA).
    Li D; Lv B; Zhang H; Lee JY; Li T
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1709-1714. PubMed ID: 25801934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1-mediated repression of mutagenic end-joining of DNA double-strand breaks requires complex formation with BACH1.
    Dohrn L; Salles D; Siehler SY; Kaufmann J; Wiesmüller L
    Biochem J; 2012 Feb; 441(3):919-26. PubMed ID: 22032289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the BRCA1 BRCT interaction with the proteins ATRIP and BAAT1.
    Liu X; Ladias JA
    Biochemistry; 2013 Oct; 52(43):7618-27. PubMed ID: 24073851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA transitions induced by binding of PARP-1 to cruciform structures in supercoiled plasmids.
    Chasovskikh S; Dimtchev A; Smulson M; Dritschilo A
    Cytometry A; 2005 Nov; 68(1):21-7. PubMed ID: 16200639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential binding of IFI16 protein to cruciform structure and superhelical DNA.
    Brázda V; Coufal J; Liao JC; Arrowsmith CH
    Biochem Biophys Res Commun; 2012 Jun; 422(4):716-20. PubMed ID: 22618232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unsolved mystery: the role of BRCA1 in DNA end-joining.
    Saha J; Davis AJ
    J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i18-i24. PubMed ID: 27170701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of Local DNA Structures by p53 Protein.
    Brázda V; Coufal J
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional assessment of intrinsic disorder central domains of BRCA1.
    Yadav LR; Rai S; Hosur MV; Varma AK
    J Biomol Struct Dyn; 2015; 33(11):2469-78. PubMed ID: 25616417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional variant analyses (FVAs) predict pathogenicity in the BRCA1 DNA double-strand break repair pathway.
    Loke J; Pearlman A; Upadhyay K; Tesfa L; Shao Y; Ostrer H
    Hum Mol Genet; 2015 Jun; 24(11):3030-7. PubMed ID: 25652403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BRCT regions of tumor suppressor BRCA1 and of XRCC1 show DNA end binding activity with a multimerizing feature.
    Yamane K; Katayama E; Tsuruo T
    Biochem Biophys Res Commun; 2000 Dec; 279(2):678-84. PubMed ID: 11118345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping and conformational characterization of the DNA-binding region of the breast cancer susceptibility protein BRCA1.
    Naseem R; Sturdy A; Finch D; Jowitt T; Webb M
    Biochem J; 2006 May; 395(3):529-35. PubMed ID: 16460311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and functional characterization of a PP1-binding site in BRCA1.
    Hsu LC
    Biochem Biophys Res Commun; 2007 Aug; 360(2):507-12. PubMed ID: 17603999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions?
    Mark WY; Liao JC; Lu Y; Ayed A; Laister R; Szymczyna B; Chakrabartty A; Arrowsmith CH
    J Mol Biol; 2005 Jan; 345(2):275-87. PubMed ID: 15571721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFI16 Preferentially Binds to DNA with Quadruplex Structure and Enhances DNA Quadruplex Formation.
    Hároníková L; Coufal J; Kejnovská I; Jagelská EB; Fojta M; Dvořáková P; Muller P; Vojtesek B; Brázda V
    PLoS One; 2016; 11(6):e0157156. PubMed ID: 27280708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel domain of BRCA1 interacts with p53 in breast cancer cells.
    Buck M
    Cancer Lett; 2008 Sep; 268(1):137-45. PubMed ID: 18501503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conserved BRCT regions of TopBP1 and of the tumor suppressor BRCA1 bind strand breaks and termini of DNA.
    Yamane K; Tsuruo T
    Oncogene; 1999 Sep; 18(37):5194-203. PubMed ID: 10498869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polo-like kinase 1 mediates BRCA1 phosphorylation and recruitment at DNA double-strand breaks.
    Chabalier-Taste C; Brichese L; Racca C; Canitrot Y; Calsou P; Larminat F
    Oncotarget; 2016 Jan; 7(3):2269-83. PubMed ID: 26745677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.